Pharma BD Deal Intelligence
A small $73M bolt-on that built Teva's API arm — an arm Teva has spent two years failing to sell off as non-core
Full analysis, sources & comparables →Teva closed acquisition of Honeywell Pharmaceutical Fine Chemicals S.r.l., an Italian subsidiary of Honeywell International Inc. and producer of active…
Teva announced a massive restructuring with 14,000 jobs to be cut, representing 25% of employees, intended to cut $3 billion from an annual cost base of…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
Closed during 2002. API manufacturer in Italy, renamed Teva PFC. Tier 1 (Teva IR) verified.
A small $73M bolt-on that built Teva's API arm — an arm Teva has spent two years failing to sell off as non-core
Assessment window: 15yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd. / Honeywell Pharmaceutical Fine Chemicals S.r.l (this deal) | 2002 | — | 38 |
| Teva Pharmaceutical Industries Ltd. / Auspex Pharmaceuticals | 2015 | $3.5B | 86 |
| Teva Pharmaceutical Industries Ltd. / Biogal Pharmaceutical | 1995 | — | 82 |
| Teva Pharmaceutical Industries Ltd. / Sicor Inc. | 2003 | $3.4B | 68 |
| Teva Pharmaceutical Industries Ltd. / Ivax Corporation | 2006 | $7.4B | 63 |
| Teva Pharmaceutical Industries Ltd. / Novopharm Limited | 2000 | $600M | 62 |
| Teva Pharmaceutical Industries Ltd. / Ivax Corporation | 2005 | $7.4B | 62 |
← Browse all deals · How we score deals
More: 2002 deals · Teva Pharmaceutical Industries Ltd. deals